BlackRock, Inc. (BLK) 13D/13G Filings for Viridian Therapeutics, Inc. (VRDN)

BlackRock, Inc. 13D and 13G filings for Viridian Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-01-29
3:26 pm
Purchase		 2023-12-31 13G Viridian Therapeutics, Inc.
VRDN		 BlackRock Inc.
BLK		 3,426,450
6.500%		 664,894increase
(+24.08%)		 Filing
2023-02-03
12:10 pm
Purchase		 2022-12-31 13G Viridian Therapeutics, Inc.
VRDN		 BlackRock Inc.
BLK		 2,761,556
6.900%		 2,761,556increase
(New Position)		 Filing